South African pharmaceutical company Aspen Pharmacare said on Monday it had entered into a preliminary agreement with Johnson & Johnson to commercially manufacture its COVID-19 vaccine candidate.
Aspen said it had agreed to provide capacity required for the manufacture of J&J’s vaccine candidate, which is still undergoing clinical trials, at its Port Elizabeth facility.
Aspen will perform formulation, filling and secondary packaging of the vaccine for supply to Johnson & Johnson, the company said.
Follow us on:
The 34th anniversary of German Unity celebrated in Lagos, was hosted by Consul General Weert…
Matt Gaetz has said he will not return to Congress after withdrawing as Trump’s DOJ…
President Tinubu has sought Senate confirmation of Olufemi Oluyede as Chief of Army Staff, citing…
Israeli PM Netanyahu faces potential arrest in the UK as Downing Street pledges to fulfill…
A second Australian teenager has died of suspected methanol poisoning in Laos, bringing to six…
https://www.youtube.com/watch?v=mFlFl1mPGC8 The arrest of self-proclaimed Prime minister of the Biafra Republic, Simon Ekpa who was…